In the TRANSCEND-T2D-1 trial, which enrolled 537 adults with type 2 diabetes, participants taking the highest dose of retatrutide at 12 mg lost an average of 36.6 lbs, or 16.8% of their body weight, over 40 weeks
Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.
The Department of Health said: "The Medicines and Healthcare products Regulatory Agency (MHRA) continuously works to identify those unlawfully trading in medicines and will use its powers to take appropriate enforcement action." Dr Alison Cave, the MHRA's chief safety officer, said: "Buying prescription-only medicines without a prescription from illegally trading suppliers significantly increases the risk of receiving something which is either fake or not licensed for use in the UK
A Note on the Evolving Regulatory Landscape The regulatory environment for compounded GLP-1 medications has tightened significantly since the shortage period ended
The oral pills can also be a future option for people who wish to transition away from injectables
Taste perception and implicit attitude toward sweet related to body mass index and soft drink supplementation
![Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases](https://ars.els-cdn.com/content/image/1-s2.0-S0001731023008505-fx1.jpg)
